What risk-enhancing factors should be considered when deciding whether to initiate statin therapy for those in the 5% to <7.5% risk range?
Clinicians should assess priorities for health care, perceived ASCVD risk, and prior risk reduction experiences and should use best practices for communicating risk to arrive at a shared risk decision. The presence of risk-enhancing factors is probably the best indicator favoring initiation of statin therapy (Table 3 in Section 2.2.).